-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624.O3.6 624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Mature T- and NK-cell Lymphomas: Prospective Trials and a Retrospective Analysis

Symposia: Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Antibody Therapy, adult, epidemiology, Lymphomas, non-Hodgkin lymphoma, Clinical Research, Combination therapy, T Cell lymphoma, Diseases, aggressive lymphoma, Therapies, Immunotherapy, Lymphoid Malignancies, registries, Study Population, Human
Monday, December 12, 2022: 4:30 PM-6:00 PM
271-273 (Ernest N. Morial Convention Center)
Anna Sureda, Hematology Department, Institut Català d'Oncologia - Hospitalet and Paola Ghione, MD, Roswell Park Comprehensive Cancer Center
No relevant conflicts of interest to declare.
4:30 PM

Qingqing Cai, PhD1, Panpan Liu, MD, PhD1*, Yi Xia, MD, PhD1*, Jun Cai1*, Huiqiang Huang, MD, PhD2, Zhiming Li1*, Hui Zhou3*, Yajun Li, MD, PhD3*, Hanyu Wang, MD, PhD4*, Ying Huang, MD, PhD5*, Gao Yan, PhD1 and Xueyi Pan, MD, PhD6*

1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department of Medical Oncology, Sun Yat-Sen Univ. Cancer Ctr., Guangzhou, Guangdong, China
3Department of Lymphoma and Hematology, Hunan Cancer Hospital, Xiangya School of Medicine, the Affiliated Cancer Hospital, Changsha, China
4Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Gaungzhou, China
5Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
6Department of Hematology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

4:45 PM

Olivier Tournilhac, MD, PhD1*, Solene Lecolant, PharmD2*, Maya Hacini, MD3*, Krimo Bouabdallah, MD4*, Sebastien Bailly5*, Kamel Laribi, MD6*, Thibaut Belmondo, MD7*, Marie Maerevoet8*, Loic Ysebaert, MD, PhD9*, Stéphanie Guidez, MD10*, Steven Le Gouill, MD, PhD11, Christophe Bonnet, MD, PhD12*, Marc Andre, MD13*, Jehan Dupuis, MD14*, Catherine Thieblemont, MD, PhD15, Emmanuel Bachy, MD, PhD16*, Nicolas Daguindau, MD17*, Franck Morschhauser, MD, PhD18,19*, Sabine Tricot, MD20*, Pierre Feugier, MD21*, Anne Banos, MD22*, Thierry Lamy23*, Adrien Chauchet, MD24*, Emmanuel Gyan, MD, PhD25, Guillaume Cartron, MD, PhD26*, Hassan Farhat, MD27*, Vincent Camus, MD28*, Bernard Drenou29*, Hacene Zerazhi30*, David Sibon, MD, PhD31*, Emmanuelle Nicolas-Virelizier, MD32*, Caroline Delette, MD33*, Sylvia Snauwaert, MD34*, Nicole Straetmans, MD, PhD35, Richard Delarue, MD36, Marie Parrens, MD, PhD37*, Samuel Griolet38*, Philippe Gaulard, MD, PhD39*, Marie-Helene Delfau-Larue, MD PhD40*, Laurence De Leval, MD41 and Gandhi Laurent Damaj, MD, PhD, Prof42*

1Service d'Hématologie Clinique et Thérapie Cellulaire, CHU, Université Clermont Auvergne EA7453 Chelter CIC-1405, Clermont-Ferrand, FRA
2Department of Biological Hematology and Immunology, Laboratory of Immunology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Creteil, France
3Hematologie, Centre Hospitalier Metropole Savoie, Chambery, FRA
4Hematology and Cellular Therapy Department, CHU Bordeaux, Pessac, France
5Hématologie et Thérapie Cellulaire, CHU de Clermont-Ferrand, Clermont-Ferrand, France
6Hématologie clinique, CH Le Mans, Le Mans, France
7Department of Biological Hematology and Immunology; Laboratory of Immunology;, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Créteil, France
8Hematology, Institut Jules Bordet, ULB, Brussels, Belgium
9IUCT Oncopole, Toulouse, France
10Service Hématologie et Thérapie cellulaire, CIC INSERM 1402, CHU POITIERS, Poitiers, France
11Institut Curie Comprehensive Cancer Center, Paris, France
12Clinical Hematology, CHU University of Liège, Liège, Belgium
13Department of Hematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
14Lymphoid Malignancies Department, Henri Mondor University Hospital, Créteil, France
15Hemato-oncology Department, Université de Paris Cité/Saint-Louis University Hospital/AP-HP, Paris, France
16Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
17Hematology Department, CH Annecy Genevois, Annecy, France
18CHU Lille, Service des Maladies du Sang, F-59000, Lille, France
19Department of Clinical Hematology, Centre Hospitalier Regional Universitaire (CHRU) de Lille and Unite Groupe de Recherche sur les Formes Injetables et les Technologies Associees (GRITA), Universite de Lille 2, Lille, France
20Service d'Hématologie Clinique, CH de Valenciennes, Valenciennes, France
21Department of Hematology, Henri Poincaré University, CHU NANCY BRABOIS, Vandoeuvre Les Nancy, France
22Service d'Hematologie, Centre Hospitalier De Bayonne, Bayonne, FRA
23CHU de Rennes, Service d’Hématologie Clinique, Rennes, France
24Hematology, CHU de Besancon, Besancon, FRA
25Service D'Hematologie et Therapie Cellulaire, CHU de Tours, Tours Cedex, France
26Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
27Department of Hematology, Hôpital André Mignot, Centre Hospitalier de Versailles, Le Chesnay, France
28Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France
29Service d'Hématologie, Groupe Hospitalier de la Région Mulhouse Sud Alsace (GHRMSA), Mulhouse, France
30Hématologie, CH Avignon, Avignon, France
31Faculty of Medicine and Health, Campus Henri Mondor, Paris-Est Creteil University, Creteil, France
32Hematology, Centre Leon Berard, Lyon, France
33Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Amiens, France
34AZ Sint-Jan, Brugge, Belgium
35Department of Hematology, Cliniques Universitaires Saint-Luc,, Woluwe Saint Lambert, BEL
36Hematology Department / Hemophilia Center, Necker University Hospital, AP-HP, Paris, France
37Department of Pathology, University of Bordeaux, Bordeaux, France
38Centre Hospitalier Lyon Sud, Lymphoma Academic Research Organisation (LYSARC), Lyon, France
39Department of Pathology, Henri Mondor Hospital, APHP, Paris Est-Créteil (UPEC) University Faculty, INSERM UMR-S 955, Créteil, France
40Biological Hematology and immunology Department, APHP, CHU Henri Mondor, Creteil, France
41Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
42Department of Hematology, Hematology Institute University Hospital School of Medicine, Caen, France

5:00 PM

Philipp Berning1*, Maud Ngoya2*, Norbert Schmitz, MD1*, Hervé Finel2*, Ariane Boumendil, PhD2*, Won-Seog Kim, MD, PhD3*, Fengrong Wang4*, Xiao-jun Huang4, Olivier Hermine, MD, PhD5, Laure Philippe, MD5*, Lucile Couronne5*, Arnaud Jaccard6*, Daihong Liu, MD7, Depei Wu8, Hans Christian Reinhardt, MD9, Yves Chalandon, MD10, Eva Maria Wagner, MD11, Mi Kwon, MD, PhD12*, Xi Zhang, M.D., Ph.D.13*, Ben Carpenter, MD14*, Ibrahim Yakoub-Agha, MD, PhD15, Gerald Wulf, MD16*, Javier López Jiménez, MD, PhD17*, Jaime Sanz, MD18*, Hélène Labussière-Wallet19*, Avichai Shimoni, MD20*, Peter Dreger, MD21, Anna Sureda22 and Bertram Glass23*

1Department of Medicine A, University Hospital Münster, Münster, Germany
2EBMT Lymphoma Working Party Paris Office, Paris, France
3Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
4Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
5Department of Hematology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
6Department of Hematology, CHU Limoges, Limoges, France
7Department of Hematology, Chinese PLA General Hospital, Beijing, China
8Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
9Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany
10Department of Hematology, Geneva University Hospital, Geneva, Switzerland
11Department of Haematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany
12Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
13Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
14Royal Free and University College Medical School, London, United Kingdom
15CHU de Lille LIRIC, INSERM U995, Université de Lille, Lille, France
16Department of Hematology and Oncology, Georg-August-University of Göttingen, Göttingen, Germany
17Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
18Avinguda Fernando Abril Martorell, Hospital Universitario La Fe, Valencia, Valencia, Spain
19Service Hematologie, Centre Hospitalier Lyon Sud, Pavillon Marcel Bérard -Bat 1G, Lyon, France
20Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
21Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany
22Hematology Department, Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
23Clinic for Hematology, Oncology, Tumorimmunology and Palliative Care, Helios Clinic Berlin-Buch, Berlin, Germany

5:15 PM

Bradley M. Haverkos, MD, MS, MPH1, Jasmine Zain, MD2, Manali K. Kamdar, MD1, Alexander Neuwelt, MD3*, Eduardo Davila, PhD4*, Xander Bradeen1*, Steven M. Bair, MD1, Jagar Jasem, MD1*, Emily Berens5*, Clayton Smith, MD6*, Diana Abbott, PhD7* and Pierluigi Porcu, MD8

1Division of Hematology, University of Colorado, Aurora, CO
2City of Hope Comprehensive Cancer Center, Duarte, CA
3Virginia Commonwealth University, Richmond, VA
4Division of Oncology, University of Colorado, Aurora, CO
5Oncology Clinical Research Support Team, University of Colorado, Aurora, CO
6Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
7Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Denver, CO
8Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA

5:30 PM

Jehan Dupuis, MD1*, Kunihiro Tsukasaki, MD, PhD2, Emmanuel Bachy, MD, PhD3*, Franck Morschhauser, MD, PhD4*, Guillaume Cartron, MD, PhD5*, Noriko Fukuhara, MD, PhD6, Nicolas Daguindau, MD7*, René-Olivier Casasnovas, MD, PhD8*, Sylvia Snauwaert, MD9*, Rémy Gressin, MD10*, Christopher P. Fox11*, Francesco Annibale d'Amore, MD, DMSc12, Philipp B. Staber, MD, PhD13, Argyrios Gkasiamis, MD14, Mitsufumi Nishio, MD, PhD15, Luc-Matthieu Fornecker, MD, PhD16*, Marie-Helene Delfau17*, Nouhoum Sako, PhD18*, Sebastien Mule, MD, PhD19,20*, Laurence De Leval, MD21, Philippe Gaulard, MD, PhD22,23* and Francois Lemonnier24*

1Lymphoid Maligancies, Henri Mondor Hospital, Créteil, France
2Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan
3Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
4Hematology Department, Lille University Hospital, Lille, France
5Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
6Department of Hematology, Tohoku University School of Medicine, Sendai, Japan
7Hematology Department, CH Annecy Genevois, Annecy, France
8Hématologie Clinique, CHU Dijon Bourgogne, Dijon, France
9AZ Sint-Jan, Brugge, Belgium
10Department of Hematology, University, Grenoble, France
11Department of Hematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
12Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
13Medical University Vienna, Vienna, Austria
14Bristol Myers Squibb, Boudry, Switzerland
15Bristok Myers Squibb, tokyo, Japan
16Institut De CancéRologie Strasbourg Europe, Strasbourg, France
17Department of Immunology, University Hospital, Creteil, France
18Institut Mondor de recherche biomédicale, Hôpital Henri Mondor, APHP, Créteil, France
19Radiology and Medical Imaging, Henri Mondor Hospital, APHP, Créteil, France
20Paris Est-Créteil University, Créteil, France
21Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
22INSERMU955 équipe 9, Institut Mondor de Recherche Biomédicale, Créteil, France
23Département de Pathologie, Hôpital Henri Mondor & Université Paris Est Créteil, Creteil, France
24Unité Hémopathie Lymphoïde, Hôpital Henri Mondor & Université Paris Est Créteil, Créteil, France

5:45 PM

Owhofasa O. Agbedia, MD, MPH1, Rishab Prakash, BS2*, Jie Xu, MD3*, Melody R. Becnel, MD2, Ranjit Nair, MD2, Raphael E Steiner, MD2, Lei Feng, MS4*, Hun Ju Lee, MD2, Paolo Strati, MD2, Sairah Ahmed, MD2, Simrit Parmar, MD, MSCI2, Yago Nieto, MD5, Chitra Hosing, MD5, Jason Westin, MD2, Loretta J. Nastoupil, MD6, Ann Vo2*, Felipe Samaniego, MD2, Nathan H. Fowler, MD2, Neeraj Saini, MD5, Issa F. Khouri, MD5, Jin S. Im, MD, PhD7, Luis Fayad, MD2, Preetesh Jain, MBBS, MD, DM, PhD2, Michael L. Wang, MD2, Roberto N. Miranda, MD3*, Francisco Vega, MD, PhD3, Jeffrey Medeiros, MD, PhD3*, Yasuhiro Oki8, Christopher R. Flowers, MD2, Sattva S. Neelapu, MD9 and Swaminathan P. Iyer, MD2

1Division Of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas,, Houston, TX
8Genentech, Inc., South San Francisco, CA
9Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

*signifies non-member of ASH